TRANILAST is primarily used as an anti-allergic agent, effectively inhibiting the release of inflammatory mediators like histamine and prostaglandins from mast cells. It is commonly prescribed for the treatment of bronchial asthma, allergic rhinitis, and atopic dermatitis, helping to alleviate symptoms such as itching, redness, and swelling. Additionally, TRANILAST has shown potential in preventing keloid and hypertrophic scar formation by suppressing fibroblast proliferation and collagen synthesis. Recent studies also explore its application in treating fibrotic diseases, including pulmonary fibrosis and cardiac fibrosis, due to its anti-fibrotic properties. Its versatility makes it a valuable compound in both dermatological and systemic therapeutic contexts.